Favre Nicole M, Sabih Quratulain, L'Huillier Joseph C, Takabe Kazuaki, Cappuccino Helen
Department of Surgery, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences the State University of New York, Buffalo, NY 14203, USA.
Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
World J Oncol. 2022 Aug;13(4):235-240. doi: 10.14740/wjon1513. Epub 2022 Aug 23.
Syringomatous tumor of the nipple (SyT), previously known as syringomatous adenoma of the nipple (SAN) was originally described in 1983 as a rare benign tumor of the sweat duct. It is a rare benign tumor arising from the skin adnexal eccrine glands that can be misdiagnosed as invasive carcinoma due to its infiltrative nature, resulting in overtreatment. We report clinical, histopathologic, and surgical findings of a case of infiltrating syringomatous adenoma in a 40-year-old female as well as a literature review of previous cases. A high index of suspicion is required to make the diagnosis of SyT and prevent overtreatment.
乳头汗腺腺瘤样瘤(SyT),以前称为乳头汗腺腺瘤(SAN),最初于1983年被描述为一种罕见的汗腺导管良性肿瘤。它是一种起源于皮肤附属器小汗腺的罕见良性肿瘤,由于其浸润性,可能被误诊为浸润性癌,从而导致过度治疗。我们报告了一例40岁女性浸润性汗腺腺瘤的临床、组织病理学和手术结果,并对既往病例进行了文献复习。诊断SyT需要高度的怀疑指数,以防止过度治疗。